These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10472974)

  • 1. Thallium-201 single-photon emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck.
    Mukherji SK; Gapany M; Phillips D; Neelon B; O'Brien S; McCartney W; Buejenovich S; Parekh JS; Noordzij JP; Castillo M
    AJNR Am J Neuroradiol; 1999 Aug; 20(7):1215-20. PubMed ID: 10472974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult primary tumors of the head and neck: accuracy of thallium 201 single-photon emission computed tomography and computed tomography and/or magnetic resonance imaging.
    van Veen SA; Balm AJ; Valdés Olmos RA; Hoefnagel CA; Hilgers FJ; Tan IB; Pameijer FA
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):406-11. PubMed ID: 11296049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thallium-201 SPECT in the diagnosis of head and neck cancer.
    Valdés Olmos RA; Balm AJ; Hilgers FJ; Koops W; Loftus BM; Tan IB; Muller SH; Hoefnagel CA; Gregor RT
    J Nucl Med; 1997 Jun; 38(6):873-9. PubMed ID: 9189132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 201T1 SPECT for predicting early treatment response in patients with squamous cell carcinoma of the extracranial head and neck treated with nonsurgical organ preservation therapy: initial results.
    Mukherji SK; Gapany M; Neelon B; McCartney W
    J Comput Assist Tomogr; 2000; 24(1):146-51. PubMed ID: 10667674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thallum-201 single-proton emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck.
    O'Tuama LA; Young Poussaint T
    AJNR Am J Neuroradiol; 2001; 22(10):1983-4. PubMed ID: 11733339
    [No Abstract]   [Full Text] [Related]  

  • 6. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
    Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
    Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
    Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
    Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of thallium-201 SPET and CT/MRI in the detection of residual/recurrent squamous cell carcinoma of the oral cavity.
    Lee JK; Tyan YS; Huang WS
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):528-31. PubMed ID: 14722682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of thallium-201 and F-18 FDG SPECT uptake in squamous cell carcinoma of the head and neck.
    Mukherji SK; Drane WE; Tart RP; Landau S; Mancuso AA
    AJNR Am J Neuroradiol; 1994 Nov; 15(10):1837-42. PubMed ID: 7863932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of single-photon emission computed tomography/computed tomography for sentinel lymph node localization in head and neck cutaneous malignancy.
    Remenschneider AK; Dilger AE; Wang Y; Palmer EL; Scott JA; Emerick KS
    Laryngoscope; 2015 Apr; 125(4):877-82. PubMed ID: 25388656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary experience with thallous chloride T1 201-labeled single-photon emission computed tomography scanning in head and neck cancer.
    Gregor RT; Valdés-Olmos R; Koops W; Balm AJ; Hilgers FJ; Hoefnagel CA
    Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):509-14. PubMed ID: 8615968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of cervical lymph node metastasis with different imaging methods in patients with head and neck squamous cell carcinoma.
    Akoğlu E; Dutipek M; Bekiş R; Değirmenci B; Ada E; Güneri A
    J Otolaryngol; 2005 Dec; 34(6):384-94. PubMed ID: 16343398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlative 201Tl SPECT, MRI and ex vivo 201Tl uptake in detecting and characterizing cervical lymphadenopathy in head and neck squamous cell carcinoma.
    Valdés Olmos RA; Koops W; Loftus BM; Liem IH; Gregor RT; Hoefnagel CA; Hilgers FJ; Balm AJ
    J Nucl Med; 1999 Sep; 40(9):1414-9. PubMed ID: 10492358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined SPECT/CT improves detection of initial bone invasion and determination of resection margins in squamous cell carcinoma of the head and neck compared to conventional imaging modalities.
    Kolk A; Schuster T; Chlebowski A; Lange P; Scheidhauer K; Kesting M; Bissinger O; Schwaiger M; Dinges J; Weitz J
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1363-74. PubMed ID: 24573657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of CT surveillance for primary site recurrence of squamous cell carcinoma of the head and neck.
    Sullivan BP; Parks KA; Dean NR; Rosenthal EL; Carroll WR; Magnuson JS
    Head Neck; 2011 Nov; 33(11):1547-50. PubMed ID: 21990217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
    Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of undifferentiated carcinoma of nasopharyngeal type with thallium-201 and technetium-99m MIBI SPECT.
    Sobic-Saranovic DP; Pendjer IP; Kozarevic NDj; Artiko VM; Mikic AA; Obradovic VB
    Otolaryngol Head Neck Surg; 2007 Sep; 137(3):405-11. PubMed ID: 17765766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of positron emission tomography and CT with 18F-FDG PET-CT in follow-up of patients treated for head and neck squamous cell carcinoma].
    Rivière D; Morvan JB; Fakhry N; Vatin L; Cathelinaud O; Bousquet F; Giovanni A; Verdalle P
    Rev Laryngol Otol Rhinol (Bord); 2014; 135(3):127-33. PubMed ID: 26521355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer.
    McDermott M; Hughes M; Rath T; Johnson JT; Heron DE; Kubicek GJ; Kim SW; Ferris RL; Duvvuri U; Ohr JP; Branstetter BF
    AJNR Am J Neuroradiol; 2013 Aug; 34(8):1632-6. PubMed ID: 23639557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
    Sagardoy T; Fernandez P; Ghafouri A; Digue L; Haaser T; de Clermont-Galleran H; Castetbon V; de Monès E
    Head Neck; 2016 Apr; 38 Suppl 1():E1271-6. PubMed ID: 26315809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.